Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Elizabeth M Kudlacz. (1998) Combined tachykinin receptor antagonists for the treatment of respiratory diseases. Expert Opinion on Investigational Drugs 7:7, pages 1055-1062.
Read now
Read now
Articles from other publishers (7)
Nadia Guajardo, Claudia Bernal, Lorena Wilson & Zaida Cabrera. (2015) Asymmetric hydrolysis of dimethyl-3-phenylglutarate in sequential batch reactor operation catalyzed by immobilized Geobacillus thermocatenulatus lipase. Catalysis Today 255, pages 21-26.
Crossref
Crossref
Marc GerspacherChristine LewisHoward A. BallColin HowesNatarajan SubramanianKarin RyffelJohn R. Fozard. (2003)
Stereoselective Preparation of
N
-[(
R,R
)-(
E
)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-
N
-methyl-3,5-bis(trifluoromethyl)benzamide, a Potent and Orally Active Dual Neurokinin NK
1
/NK
2
Receptor Antagonist
. Journal of Medicinal Chemistry 46:16, pages 3508-3513.
Crossref
Crossref
Robert Mah, Marc Gerspacher, Andreas von Sprecher, Stefan Stutz, Vincenzo Tschinke, Gary P. Anderson, Claude Bertrand, Natarajan Subramanian & Howard A. Ball. (2002) Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists. Bioorganic & Medicinal Chemistry Letters 12:16, pages 2065-2068.
Crossref
Crossref
Marc Gerspacher, Luigi La Vecchia, Robert Mah, Andreas von Sprecher, Gary P. Anderson, Natarajan Subramanian, Kathleen Hauser, Heinrich Bammerlin, Sabine Kimmel, Viviane Pawelzik, Karin Ryffel & Howard A. Ball. (2001) Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N′-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N′-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamides. Bioorganic & Medicinal Chemistry Letters 11:23, pages 3081-3084.
Crossref
Crossref
Marc Gerspacher, Andreas von Sprecher, Robert Mah, Gary P. Anderson, Claude Bertrand, Natarajan Subramanian, Kathleen Hauser & Howard A. Ball. (2000) N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist. Bioorganic & Medicinal Chemistry Letters 10:13, pages 1467-1470.
Crossref
Crossref
David C. Horwell, Martyn C. Pritchard & Jenny Raphy. 1999. Advances in Amino Acid Mimetics and Peptidomimetics Volume 2. Advances in Amino Acid Mimetics and Peptidomimetics Volume 2
165
190
.
C. WalpoleS. Y. KoM. BrownD. BeattieE. CampbellF. DickensonS. EwanG. A. HughesM. LemaireJ. LerpiniereS. PatelL. Urban. (1998)
2-Nitrophenylcarbamoyl-(
S
)-prolyl-(
S
)-3-(2-naphthyl)alanyl-
N
-benzyl-
N
- methylamide (SDZ NKT 343), a Potent Human NK
1
Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models
. Journal of Medicinal Chemistry 41:17, pages 3159-3173.
Crossref
Crossref